Destabilization of vascular endothelial growth factor mRNA by the zinc-finger protein TIS11b

被引:92
|
作者
Ciais, D
Cherradi, N
Bailly, S
Grenier, E
Berra, E
Pouyssegur, J
LaMarre, J
Feige, JJ
机构
[1] CEA, DRDC ANGIO, INSERM EMI 01 05, Dept Cellular Responses & Dynam, F-38054 Grenoble 9, France
[2] Ctr Antoine Lacassagne, CNRS, UMR 6543, Inst Signalling Dev Biol & Canc Res, F-06189 Nice, France
关键词
VEGF; TIS11b; mRNA stability; AU-rich element;
D O I
10.1038/sj.onc.1207939
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Vascular endothelial growth factor (VEGF) is an angiogenic cytokine, which plays a major role in tumor angiogenesis. VEGF mRNA expression is controlled by hypoxia, growth factors and hormones through both transcriptional and post-transcriptional mechanisms. VEGF mRNA has a short half-life and its abundance is regulated by the binding of stabilizing (HuR, hRNP-L) and still uncharacterised destabilizing proteins to its 3'-untranslated region. Here, we report that the ACTH-regulated zinc-finger protein TIS11b and its homologs TIS11 and TIS11d interact with the 3'-untranslated region of VEGF mRNA and decrease its stability (half-life reduced from 130 to 60 min). Within the 2201 by 3'-untranslated region of VEGF mRNA, we identified a 75 by domain, containing two consensus AU-rich motifs, which binds TIS11b and mediates its destabilizing activity. Ribonucleoprotein (RNP) complex immunoprecipitation experiments allowed us to demonstrate that the interaction between TIS11b and VEGF 3'-untranslated region occurs in live cells. Knocking down TIS11b expression in primary adrenocortical cells with small interfering (si)RNAs clearly indicated that TIS11b participates in the control of both basal and, to a larger extent, ACTH-induced VEGF mRNA expression levels. TIS11b is the first VEGF mRNA-destabilizing protein identified so far and therefore appears as a new potential target in antiangiogenic therapies.
引用
收藏
页码:8673 / 8680
页数:8
相关论文
共 50 条
  • [31] Expression of mRNA vascular endothelial growth factor in hypospadias patients
    Yuri, Prahara
    Gunadi
    Lestari, Rahmadani P.
    Fardilla, Firly P.
    Dachlan, Ishandono
    BMC UROLOGY, 2021, 21 (01)
  • [32] Expression of mRNA vascular endothelial growth factor in hypospadias patients
    Prahara Yuri
    Rahmadani P. Gunadi
    Firly P. Lestari
    Ishandono Fardilla
    BMC Urology, 21
  • [33] Vascular endothelial growth factor mRNA in eutopic and ectopic endometrium
    Kressin, P
    Wolber, EM
    Wodrich, H
    Meyhöfer-Malik, A
    Buchweitz, O
    Diedrich, K
    Malik, E
    FERTILITY AND STERILITY, 2001, 76 (06) : 1220 - 1224
  • [34] LOCALIZATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR mRNA IN HUMAN TROPHOBLAST
    Takada, Anna
    Haba, Gen
    Hayashi, Risa
    Yamate, Sumire
    Iwane, Ayako
    Isurugi, Chizuko
    Oyama, Rie
    Sugiyama, Toru
    PLACENTA, 2008, 29 (10) : 915 - 915
  • [35] Vascular endothelial growth factor (VEGF) protein and mRNA in human fetal lung in vitro.
    Acarregui, MJ
    Penisten, ST
    Snyder, JM
    PEDIATRIC RESEARCH, 1996, 39 (04) : 319 - 319
  • [36] Expression of vascular endothelial growth factor mRNA and protein in human chronic renal allograft rejection
    Otto, K
    Duchrow, M
    Broll, R
    Bruch, HP
    Strik, MW
    TRANSPLANTATION PROCEEDINGS, 2002, 34 (08) : 3134 - 3137
  • [37] Prolonged hypoxia increases vascular endothelial growth factor mRNA and protein in adult mouse brain
    Kuo, NT
    Benhayon, D
    Przybylski, RJ
    Martin, RJ
    LaManna, JC
    JOURNAL OF APPLIED PHYSIOLOGY, 1999, 86 (01) : 260 - 264
  • [38] Hypoxic stabilization of vascular endothelial growth factor mRNA by the RNA-binding protein HuR
    Levy, NS
    Chung, SM
    Furneaux, H
    Levy, AP
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (11) : 6417 - 6423
  • [39] Vascular endothelial growth factor mRNA and protein expression in airway epithelial cell lines in vitro
    Koyama, S
    Sato, E
    Tsukadaira, A
    Haniuda, M
    Numanami, H
    Kurai, M
    Nagai, S
    Izumi, T
    EUROPEAN RESPIRATORY JOURNAL, 2002, 20 (06) : 1449 - 1456
  • [40] Involvement of Tis11b, an AU-rich binding protein, in induction of apoptosis by rituximab in B cell chronic lymphocytic leukemia cells
    M Baou
    A Jewell
    A Muthurania
    R G Wickremasinghe
    K L Yong
    R Carr
    P Marsh
    J J Murphy
    Leukemia, 2009, 23 : 986 - 989